Financial News

Aveeno, Neutrogena and Listerine Fuel Business at J&J

Author Image

By: TOM BRANNA

Editor

Johnson & Johnson posted a 9.1% increase in sales to $19.5 billion for the second quarter of 2014. Positive contributors to operational results were sales of Neutrogena and Aveeno skin care products; baby care products; and international sales of Listerine mouthwash and feminine protection products, according to the company. Skin care sales rose 6.6% to $968 million, while baby care increased 3.6% to $607 million and oral care inched up 1.7% to $413 million. Worldwide consumer sales r...

Continue reading this story and get 24/7 access to Happi for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Happi Newsletters